Literature DB >> 17684027

Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy.

I Rosner, A Haddad, N Boulman, J Feld, N Avshovich, G Slobodin, M Rozenbaum.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17684027     DOI: 10.1093/rheumatology/kem068

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  6 in total

Review 1.  Behçet's syndrome in pregnancy.

Authors:  Marcus Martineau; Dorian O Haskard; Catherine Nelson-Piercy
Journal:  Obstet Med       Date:  2010-03-04

Review 2.  Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review.

Authors:  Jaume Alijotas-Reig; Enrique Esteve-Valverde; Raquel Ferrer-Oliveras; Elisa Llurba; Josep Maria Gris
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

Review 3.  [Biologics during pregnancy and breast--feeding].

Authors:  R E Fischer-Betz; M Schneider
Journal:  Z Rheumatol       Date:  2010-11       Impact factor: 1.372

4.  Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register.

Authors:  Suzanne M M Verstappen; Yvonne King; Kath D Watson; Deborah P M Symmons; Kimme L Hyrich
Journal:  Ann Rheum Dis       Date:  2011-02-28       Impact factor: 19.103

5.  Safety of Tumor Necrosis Factor Inhibitors during Pregnancy and Breastfeeding.

Authors:  Harish Raja; Eric L Matteson; Clement J Michet; Justine R Smith; Jose S Pulido
Journal:  Transl Vis Sci Technol       Date:  2012-09-21       Impact factor: 3.283

Review 6.  Tumor necrosis factor-α inhibitor therapy and fetal risk: a systematic literature review.

Authors:  Renée M Marchioni; Gary R Lichtenstein
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.